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Abstract
Designer nucleases such as TALENS and Cas9 have opened new opportunities to scarlessly edit the mammalian genome.
Here we explored several parameters that influence Cas9-mediated scarless genome editing efficiency in murine embryonic
stem cells. Optimization of transfection conditions and enriching for transfected cells are critical for efficiently recovering
modified clones. Paired gRNAs and wild-type Cas9 efficiently create programmed deletions, which facilitate identification of
targeted clones, while paired gRNAs and the Cas9D10A nickase generated smaller targeted indels with lower chance of off-
target mutagenesis. Genome editing is also useful for programmed introduction of exogenous DNA sequences at a target
locus. Increasing the length of the homology arms of the homology-directed repair template strongly enhanced targeting
efficiency, while increasing the length of the DNA insert reduced it. Together our data provide guidance on optimal design
of scarless gene knockout, modification, or knock-in experiments using Cas9 nuclease.
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Introduction
Designer site-specific nucleases such as TALENs [1,2] and
CRISPR/Cas9 [3,4] have opened the door for rapid genome
engineering. By introducing targeted double strand breaks into a
genome, these nucleases stimulate endogenous repair mechanisms.
One repair mechanism is non-homologous end joining (NHEJ), in
which a double strand break is repaired by joining the DNA ends.
NHEJ repair is error-prone and causes insertions and deletions
(indels) around the DNA break point. In the presence of a donor
DNA template with homology to the region of the DNA break,
homology-directed repair (HDR) occurs. By placing sequence
variations or exogenous DNA fragments between homology arms,
the HDR mechanism can be leveraged to program specific
insertions, deletions, or base changes at a target locus.
With the aid of designer site-specific nucleases, targeted genome
modification can be achieved with sufficient efficiency that the
desired modifications can be recovered without use of positive
selection cassettes [3–5]. This is an important advance over more
traditional gene targeting strategies, since it obviates the need to
remove the selection cassette. Selection cassette removal requires
additional handling and moreover typically leaves residual
sequences. When first described using the CRISPR/Cas9 system,
‘‘scarless’’ genome editing efficiency was in the 1–4% range [4,5].
At this efficiency, a large number of clones need to be screened to
obtain a single targeted clone. Screening strategies involving
selective amplification of cell pools containing targeted clones have
been described that overcome this limitation [6]. However,
increasing the frequency of targeted clone recovery represents an
alternative and more direct approach to optimize scarless genome
editing.
Here, we report a series of experiments that investigate several
parameters that influence the efficiency of scarless genome editing
using the CRISPR/Cas9 system. Key parameters include (a)
optimization of transfection efficiency; (b) enrichment for trans-
fected cells; (c) integration of downstream genotyping into the
design of the targeting strategy; and (d) optimizing the design of
the donor DNA template. Through these improvements, we
increased the efficiency of genome editing: we routinely achieved
30–60% efficiency for homozygous targeted gene knockout
through NHEJ, and 4% efficiency for addition of a GFP epitope
tag onto endogenous genes.
Materials and Methods
Plasmids and oligonucleotides
The pCas-9-GFP, pCas9D10A-GFP, and gRNA cloning
vectors were obtained from Addgene. The traditional MEF2C
FlagBio target vector containing the FlagBio ORF and Frt-Neo-
Frt cassette flanked by 1 kb and 4 kb homolog arms was made by
recombineering [7]. The dsDNA donor with 50 bp homolog arms
on each side was made by PCR, using primers harboring 50 bp
homology sequences. The Oct4-GFP donor with 200 bp homolog
arms was made using the Gibson assembly technique [8] using a
kit from New England Biolabs, with pCR-Blunt II-TOPO vector
(Life Technologies) as backbone.
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qPCR primers:
MLL2-qPCR-F tgttcccggctttaccacttt
MLL2-qPCR-R ggctccatgatagtgatgccc
CHD7-qPCR-F gacccagggatgatgagtctt
CHD7-qPCR-R atggggttcacggggttttc
GAPDH-qPCR-F acagtccatgccatcactgcc
GAPDH-qPCR-R gcctgcttcaccaccttcttg
gRNAs:
GFP KO gRNA #3 ggccacaagttcagcgtgtc cgg
GFP KO gRNA #4 ggcgagggcgatgccaccta cgg
GFP KO gRNA #5 ccggcaagctgcccgtgccc tgg
GFP KO gRNA #9 cttcagggtcagcttgccgt agg
SMAD2 KO gRNA #3 gccgtcttcaggtttcacac cgg
SMAD2 KO gRNA #4 tcacagtcatcatgagctca agg
CHD7 KO gRNA #1 ccagggatgatgagtctttt tgg
CHD7 KO gRNA #2 gaaaaccccgtgaaccccat ggg
MLL2 KO gRNA #1 tccgaaacatgtaaataccg cgg
MLL2 KO gRNA #2 ctgtgcccctaactgtgtag cgg
sap130 gRNA #2 catgtccaacacttaccaac tgg
primers for genotyping:
smad2-F ggctctccttcatgtcctctt
smad2-R ccagcctttagtcgtcctctt
CHD7-F ccactcctttccaggaccta
CHD7-R tcattcggttaggctgatcc
MLL2-F tttgaatccaggaggcagtt
MLL2-R gtcaaggcaggcctgatg
sap130-F ctgtgtcgcacacacaagc
sap130-R cctagggcttactggccaac
SAP130-DONOR tcatcccatgctactgctgtgaccacttcaaatatcccagttggcaagt-
gttggacatgtcgcacaaaagcctttgaggaatttgcaggc
50 bp-homolog FlagBio donor for Mef2c:
mef2c-flagbio-F gggaaagtccttcagtcaagcgcatgcgactctctgaaggat-
gggcaacagactacaaagacgatgacga
mef2c-flagbio-R gcacacacacacactgcaagaaaaaaaaaaactattaagtaataatgtga-
tcacctcgagctcggcgcgc
50 bp-homolog GFP donor for Mef2c:
mef2c-gfp-F gggaaagtccttcagtcaagcgcatgcgactctctgaaggatgg-
gcaacagtgagcaagggcgaggagct
mef2c-gfp-R gcacacacacacactgcaagaaaaaaaaaaactattaagtaata-
atgtgattacttgtacagctcgtcca
50 bp-homolog GFP donor for OCT4:
OCT4-GFP-F cctttccctctgttcccgtcactgctctgggctctcccatgcattcaaacgtga-
gcaagggcgaggagct
OCT4-GFP-R gtctacctcccttgccttggctcacagcatccccagggagggctggtgccttac-
ttgtacagctcgtcca
Gibson assembly to make 200-bp homolog donor for OCT4:
200 bp_right-F ttggtaccgagctcgcccaacgagaagagtatg
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nologies. Primer sequences are indicated in Table 1. gRNAs were
designed using the CRISPR design tool (crispr.mit.edu) [9].
Cell Culture
Mouse J1 ESCs (ATCC) were cultured on MEF-coated
gelatinized plates at 37 in 5% CO2 in ES medium. ES medium
contained Dulbecco’s modified Eagle’s medium (DMEM) (high
glucose, Life Techologies) supplemented with 15% ES-qualified
fetal bovine serum (Invitrogen), LIF (Millipore), GlutaMAX, 2-
mercaptoethanol, MEM non-essential amino acids, and penicillin/
streptomycin.
Transfection
Traditional electroporation was done using a Gene Pulser
electroporator (BioRad) at 250 V, 500 uF. Nucleofection was
performed using the mouse ESC nucleofection kit (VPH-1001;
Amaxa). Lipofectamine 3000 (Life Technologies, L3000008) and
Xfect (Clontech) were used according to manufactures’ protocols.
To enrich for transfected cells, GFP FACS was performed 48
hours after transfection. Alternatively, pgk-puromycin plasmid was
co-transfected with Cas9 in a 2:3 ratio. After 48 hours, cells were
selected in 1.5 mg/ml puromycin for 48 hours.
Genotyping and surveyor assay
Mouse ESCs were digested overnight in lysis buffer (10 mM
Tris-Hcl 7.5, 10 mM EDTA, 10 mM NaCl, 1% SDS, and 1 mg/
ml proteinase K). Genomic DNA was purified by ethanol
precipitation. PCR primers flanking the target regions were
designed by Primer 3 software. For Surveyor nuclease assay,
800 ng PCR products were melted and annealed in 1X Taq buffer
for heteroduplex formation. The hybrid DNA was treated with
1 ml enhancer S and 1 ml nuclease S according to manufacture’s
protocol. The reaction products were analyzed on 4–20% Novex
TBE polyacrylamide gels (Life Technologies), and visualized by
Sybr Gold nucleic acid staining (Life Technologies, S-11494).
Gene Expression
RNA was purified using the RNeasy mini kit (Qiagen, 74104).
cDNA synthesis was performed using Superscript III first-strand
synthesis system for RT-PCR (Life Technologies, 18080-051).
Quantitatative PCR was performed with Sybr Green chemistry,
using GAPDH as the endogenous control. Primer sequences are
indicated in Table 1.
Results
The CRISPR system offers unprecedented genome editing
capability. Ideally, such genome-editing would be scarless (i.e.
without need for a selection cassette) yet highly efficient. A major
factor that reduces the fraction of genome-edited clones in the
absence of positive selectable markers incorporated into the
modified allele is transfection efficiency. To deliver CRISPR
components more efficiently into mouse ES cells (mESCs), we
tested four different transfection methods: traditional electropora-
tion; nucleofection; and two different, recently introduced
liposomal agents (Xfect and Lipofectamine 3000 (LF3000)). We
transfected Cas9-GFP expression plasmids to mESCs, and
analyzed the percentage of GFP positive cells by fluorescence-
activated cell sorting (FACS; Figure 1). Nucleofection and LF3000
performed the best or second best in three replicate experiments
that measured the fraction of transfected cells and the mean
fluorescence intensity (Figure 1B). In subsequent experiments, we
used either nucleofection or LF3000 since these gave the highest
transfection efficiency for the pCas9-GFP plasmid, the active
reagent in these genome editing experiments.
Optimization of CRISPR-mediated gene knockout
We established a system in which we could easily monitor the
efficiency of CRISPR gene knockout. Our lab previously
described a mESC line in which a CAG-promoter driven L10a-
GFP fusion protein was knocked into the Rosa26 locus [10]. These
heterozygous L10a-GFP mESCs robustly express GFP (Fig. 2A).
We co-transfected these cells with hCas9 and a gRNA directed
against GFP (Fig. 2B). Subsequent FACS analysis showed that
21.1% of cells were GFP
2 after transfection (Fig. 2C), compared
to 0.9% in cells not treated with hCas9.
Expression of hCas9 and a target-specific gRNA causes gene
knockout by introducing a double strand break, which is repaired
by non-homologous end joining (NHEJ). In the presence of the
appropriate DNA donor, the double strand break also stimulates
homology-directed repair (HDR). We hypothesized that program-
ming a DNA donor template with a stop codon would increase the
efficiency of generating knockouts through the HDR pathway. We
tested this hypothesis on the L10a-GFP locus. We found that
hCas9+gRNA alone (NHEJ) yielded 20.760.9% GFP
– cells, while
hCas9+gRNA+DNA donor (both NHEJ and HR) yielded
34.962.3% GFP
2 cells (P,0.05; Fig. 2D). Although the knockout
efficiency varied based on the transfection efficiency, the rank
order was consistent between trials (Fig. 2D). Thus, adding a
donor oligo with stop codon increased KO efficiency compared to
hCas9 plus gRNA alone.
Next, we considered whether the number of gRNAs influenced
Cas9 knockout efficiency. We compared GFP knockout in L10a-
GFP mESCs treated with one gRNA (#3o r#4) or both. hCas9
was co-transfected with gRNA #3, gRNA #4, or both into L10a-
GFP mESCs. We observed 39.9% GFP
– cells using gRNA #3,
43.3% GFP
– cells using gRNA #4, and 49.3% using both gRNAs
(Fig. 2E). We confirmed GFP knockout by microscopic imaging of
replated, FACS-sorted GFP
– cells (Fig. 2F). Furthermore, western
Table 1. Cont.
qPCR primers:
200 bp_right-R ttgctcacgtttgaatgcatgggagag
GFP-F cattcaaacgtgagcaagggcgaggag
GFP-R ctggtgccttacttgtacagctcgtccatg
200 bp_left-F gtacaagtaaggcaccagccctccctgg
200 bp_left-R ggcgaattgggcccttatttaagaacaaaatgatgagtgacagacaggcc
doi:10.1371/journal.pone.0105779.t001
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GFP
– cells (Fig. 2G). We genotyped GFP-clones targeted by two
gRNAs by Sanger sequencing of PCR amplicons and confirmed
deletion between two gRNA cut sites. Since dual gRNAs do not
impair and may enhance knockout efficiency, and since paired
gRNAs induces a deletion that facilitates genotyping (see below), in
the following experiments we typically used two gRNAs per target
gene to simplify detection of genome modification.
The frequency of off-target Cas9 activity can be reduced using a
Cas9 point mutant, hCas9-D10A, which introduces single nicks
rather than double strand breaks [11–13]. We tested the
effectiveness of the hCas9-D10A nickase for generating gene
knockouts (Fig. 2H). When we co-transfected hCas9-D10A
nickase with one gRNA #5, the efficiency of ablating GFP was
low (1.72%), as expected since DNA nicking should not induce
NHEJ-mediated mutagenesis. The same individual gRNA co-
transfected in parallel with wild-type hCas9 yielded 43.7% GFP
–
cells. However, hCas9-D10A co-transfected with a second gRNA
designed to introduce a nick on the opposite strand with 59
overhangs (gRNA #5 and gRNA #9, Fig. 2B) [11] yielded 32.3%
GFP
– cells. While this efficiency is slightly lower than that achieved
using the wild-type hCas9, this reduction is may be a worthwhile
tradeoff for reduced off-target mutagenesis with hCas9-D10A.
Having defined parameters that permit efficient Cas9-mediated
gene knockout in mESCs, we next targeted Smad2, MLL2, and
CHD7, mutations of which have been implicated in human
congenital heart disease [14] (Fig. 3A). First, we targeted Smad2 in
NKX2.5-GFP mESCs, in which the cardiomyocyte-specific
NKX2.5 promoter drives GFP expression, by co-transfecting
pCas9-GFP with two gRNAs for Smad2. We performed GFP
FACS to enrich for cells with high Cas9-GFP expression and then
clonally expanded them. We analyzed genomic DNA from clones
to determine the Smad2 knockout efficiency. PCR amplification of
pooled genomic DNA using primers flanking both gRNA-target
sites showed that hCas9 plus two gRNAs generated the expected
full length PCR product plus a smaller product, which
corresponded to mutant alleles containing a deletion. Notably,
the smaller PCR product was more intense than the wild-type
band, suggesting highly efficient, targeted mutagenesis (Fig. 3B).
We confirmed this result by treating PCR-amplified pooled
Figure 1. Optimization of mESC transfection. A. pCas9-GFP expression plasmid was transfected into mESCs by the indicated method. GFP
fluorescence was assessed by fluorescent microscopy and FACS. Numbers indicate the fraction of GFP-expressing cells. B. Percent of transfected cells
and mean fluorescence intensity of GFP+ cells. n=3. Graphs show mean 6 s.e.m.
doi:10.1371/journal.pone.0105779.g001
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DNA, on pooled genomic DNA. Compared to untreated cells,
Cas9 with gRNA treated cells yielded additional nuclease cleavage
products (Fig. 3C). PCR genotyping showed that 32 out of 56
clones (57%) were homozygous mutants, 14 out of 56 (25%) were
heterozygous mutants, and 10 out of 56 (18%) were wild-type
(Fig. 3D–E). This likely underestimates the mutagenesis efficiency,
since the larger PCR band may actually contain smaller indel
mutations, which could occur if only one of the two gRNAs
cleaved its target.
In scarless genome editing without positive selection, enrich-
ment for transfected cells is an important step to increase the
fraction of colonies that harbor a mutation of interest. We
compared targeted Smad2 mutagenesis efficiency using FACS-
selection of GFP
+ cells transfected with Cas9-GFP (above) to an
alternative procedure in which Cas9 expression plasmid was co-
transfected with pgk-puro. 48 hours after transfection, cells
underwent 48 hours of puromycin selection. We genotyped 54
independent clonal outgrowths and obtained 19 (34%) homozy-
gous mutants, 29 (51.8%) heterozygous mutants, and 8 (14.3%)
without apparent modification (Figure 3F). These data indicate
that co-transfection with pgk-puro and transient puromycin
selection or co-expression of GFP with FACS enrichment are
both suitable for enrichment of transfected cells in Cas9 genome
editing experiments, although FACS selection for GFP may yield a
greater proportion of targeting of both alleles.
We sequenced 9 clones in which both Smad2 alleles were
mutated based on the PCR genotyping assay. The Sanger
sequencing data showed that all of these clones did indeed have
homozygous deletion of the region between the two gRNAs. We
Figure 2. Cas9 gene knockout using single or dual gRNAs. A. mESC cell line L10a-GFP, in which one Rosa26 locus expresses GFP. B.
Experimental outline and gRNAs. gRNAs #9 and #5 generate 59 overhangs for dual nickase strategy. C. Single gRNA-directed GFP inactivation. D.
Comparison of gRNA alone or gRNA+HDR donor containing a translational stop signal. n=3. Bar=s.e.m. Red circles indicate individual data points. E.
Gene inactivation frequency of single compared to paired gRNAs. F–G. Assessment of GFP expression in mESCs in the GFP-FACS fraction by
fluorescent microscopy and western blotting. H. Effective gene knockout using dual gRNAs and the hCas9-D10A nickase mutant.
doi:10.1371/journal.pone.0105779.g002
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performing western blotting. SMAD2 protein was indeed ablated
in the clones assigned the Smad2
2/2 genotype by the PCR
genotyping assay (Fig. 3G).
We used the same knockout strategy with GFP FACS
enrichment to mutate Mll2 and Chd7 in mESCs. PCR genotyping
demonstrated that mESCs targeted with hCas9-GFP and two
gRNAs were efficiently mutated at the Mll2 and Chd7 loci: 23 of
39 clones (59%) genotyped contained substantial homozygous
Mll2 deletions (Fig. 3H–I), and 16 of 48 clones (33%) genotyped
contained substantial homozygous Chd7 deletions (Fig. 3J–K). We
confirmed reduction of Mll2 and Chd7 mRNA expression in 3
independent clones of each target locus (Fig. 3I, K). Although
these clones had confirmed gene deletions, only some had reduced
transcript level, likely due to variability in nonsense-mediated
decay.
These data demonstrate that the CRISPR system achieves
highly efficient scarless genome editing at several different loci.
Using optimized transfection conditions and FACS selection of
transfected cells by co-transfected GFP fluorescence yields highly
efficient mutagenesis. Use of two gRNAs permits efficient
identification of mutated clones by PCR genotyping. The
hCas9D10A mutant also achieves efficient mutagenesis with
potentially reduced off-target activity.
Targeted DNA base changes using CRISPR
Having successfully used CRISPR to knock out genes in mouse
ES cells, we further evaluated the utility of CRISPR for targeted
gene modification, rather than simple knockout. We assessed the
efficiency of Cas9 to introduce a T.C mutation into the gene
Sap130. We used nucleofection to introduce pCas9-GFP,
Sap130-targeted gRNA, and donor oligo harboring the desired
T.C mutation into mESCs (Fig. 4A). We performed FACS
sorting to select transfected, GFP-expressing cells, and then
clonally expanded them. Conducting the surveyor nuclease assay
on pooled genomic DNA demonstrated highly efficient genome
modification, since nearly all of the PCR products were cleaved by
the nuclease (Fig. 4B). PCR amplification of genomic DNA
followed by Sanger sequencing for 48 clones showed that 4 clones
(8.3%) were homozygous for the desired T.C mutation. Of the
remaining clones, 34 (70.8%) contained different sequences at the
two alleles (‘‘heterozygous’’), 3 (6.3%) were wild-type (Fig. 4C),
and 7 (14.6%) had the same indel mutation on both alleles
(‘‘homozygous indel’’). The frequency of homozygous indel
mutants was surprising, and we confirmed this result for 2
randomly selected clones by cloning the genomic DNA PCR
product and sequencing 16 independent clones. One potential
reason for this observation is that the mutagenic event on one
allele might be transferred to the second (e.g by inter-allelic gene
conversion). Overall, our data indicate that scarless introduction of
a targeted point mutation can be efficiently achieved using this
approach.
Targeted DNA insertions using CRISPR
We next evaluated the ability of CRISPR to introduce an
exogenous DNA sequence, such as an epitope tag, into a target
locus. We already had in hand a traditional targeting vector
designed to introduce FLAG and BIO [15] epitope tags onto the
C-terminus of Mef2c. This targeting vector contained 1 kb and
4 kb homology arms, the 99 bp FLAG-BIO tag, and a 1.8 kb pgk-
Neo resistance cassette (Fig. 5A). In a traditional gene targeting
experiment without Cas9 and with G418 selection, we obtained 8
correctly targeted clones out of 192 screened mESCs (4.2%). In
comparison, we transfected the targeting vector with hCas9-GFP
Figure 3. Knockout of 3 congenital heart disease genes in mESCs. A. Experimental outline. Paired gRNAs are designed to induce a deletion
of about 100 bp. B. PCR genotyping of pooled ESC genomic DNA after Smad2 targeting. The mutant PCR product predominated. C. Surveyor
nuclease on pooled ESC genomic DNA. Red arrowheads indicate nuclease cleavage products indicative of heterodimers. D. PCR genotyping of
individual clones showing Smad2
D/D, Smad2
+/+, and Smad2
+/D clones. E–F. Frequency of Smad2 genotypes amongst clonal outgrowths, after
enrichment for transfected cells by GFP FACS or by transient puromycin selection. G. Western blot measurement of Smad2 expression in wild-type
and Smad2
D/D clones. H. Frequency of Mll2 genotypes amongst 39 genotyped clones. I. Confirmation of Mll2 inactivation in individual Mll2
D/D clones
by qRTPCR. J. Frequency of Chd7 genotypes amongst 48 genotyped clones. K. Confirmation of Chd7 inactivation in individual Chd7
D/D clones by
qRTPCR.
doi:10.1371/journal.pone.0105779.g003
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GFP
+ cells, and clonally expanded them without G418 selection.
Out of 46 clones genotyped, 9 were properly targeted (19.6%;
Fig. 5A). In comparison, omission of Cas9 yielded no correct
clones out of 24 tested (P=0.023, Fisher’s exact test; Fig. 5A).
These data show that CRISPR greatly increases HDR efficiency
and facilitates knockin gene modification of foreign DNA
sequences up to several kilobases in length.
Traditional targeting vectors have long homology regions and a
positive selectable marker to overcome inefficient endogenous
homologous recombination. Elimination of the selectable marker
and shortening the homology arms would greatly facilitate
targeting vector construction, and would obviate the need to
subsequently remove the selectable marker (usually leaving a
recombinase recognition sequence as a residual scar). We asked if
greater HDR efficiency achieved using Cas9 would permit a
simple vector consisting of the desired knockin modification
flanked by 50 base pair homology regions. We generated such a
simplified dsDNA donor to introduce the FLAG-BIO epitope tag
into the Mef2c C-terminus (Fig. 5B). The simplified targeting
vector was co-transfected with pCas9-GFP and appropriate gRNA
into mESCs. FACS-sorted, GFP
+ cells were clonally expanded.
Genotyping of DNA pooled from clones showed that there were
two PCR bands in the Cas9 co-transfected group, with the larger
amplicon arising from insertion of the FLAG-BIO tag at the
Mef2c C-terminus (Fig. 5C). Genotyping of 22 individual clones
showed that 8 (36.3%) contained the Flagbio insertion. We
validated the function of the inserted FLAG-BIO tag by
transfecting two genotype positive clones with a BirA expression
plasmid. BirA recognizes the BIO peptide and biotinylates it [15].
To test the successful tagging and biotinylation of Mef2c, ESC
lysates were incubated with streptavidin beads, and material
bound to the beads was immunoblotted with anti-FLAG antibody.
This showed that a FLAG-tagged protein with appropriate
molecular weight for MEF2C was efficiently pulled down on the
SA beads (Fig. 5D), confirming the functionality of the knockin
allele.
A 99 bp, the FLAG-BIO epitope tag is still relatively small. To
investigate the ability of Cas9 and a simplified targeting vector
containing only 50 bp homology arms to knockin a larger foreign
DNA fragment, we attempted to fuse GFP to MEF2C. This
targeting vector contained the GFP open reading frame (720 bp)
flanked by the same 50 bp homology arms as used for introduction
of FLAG-BIO (Fig. 5E). We co-transfected this targeting vector
with pCas9-GFP and Mef2c gRNA into mESCs. GFP
+ cells were
isolated by FACS and clonally expanded. Pooled DNA from
resultant clones was positive for a diagnostic PCR product
(Fig. 5F). Genotyping 46 individual clones identified 2 positive
clones (4.3%). Embryoid body differentiation of one of the positive
clones induced GFP fluorescence in regions of the embryoid body,
suggesting that the GFP tag was functional (Fig. 5G). Sequencing
of RTPCR product confirmed the desired fusion of GFP cDNA to
Mef2c. These data show that HDR driven by Cas9 can be used for
targeted insertion of a fragment several hundreds of base pairs
long using a simple targeting vector with only 50 bp homology
arms and no selectable marker.
To see if another locus can be effectively modified by this
strategy, we targeted Oct4, a transcription factor expressed in
mESCs. Oct450-GFP donor, containing 50 bp homology arms,
gRNA and Cas9 were co-transfected into mESCs. In this case, it
was not possible to enrich for transfected cells by FACS. After 10
days of ESC culture, FACS analysis showed that this treatment
generated 0.7% GFP
+ cells (Fig. 6A). Since this experiment did
not enrich for transfected cells, the frequency of desired targeting
amongst transfected cells is likely more then 5-fold higher
(assuming a transfection efficiency of 20%). Genotype positive
clone #38 stably expressed OCT4-GFP, as confirmed by
fluorescent imaging and western blotting (Fig. 6B–C).
To determine if longer homology arms could increase efficiency
of HR-mediated knockin, we tested 200 bp homology arms, as
arms of this length can easily be synthesized as oligonucleotides.
Using Gibson assembly, we generated an Oct4200-GFP donor,
containing 200 bp homology arms. We introduced this construct
into mESCs with Cas9 and appropriate gRNA. After 10 days of
ESC culture, FACS analysis showed that this treatment generated
5.8% GFP
+ cells (Fig. 6A). Genotyping of GFP
+ clones confirmed
appropriate knockin at the Oct4 locus (Fig. 6D). These data show
Figure 4. Cas9-mediated introduction of a single base change. A. Sap130 targeting strategy. The blue arrow indicates the gRNA targeting the
reverse strand with the tail and tip representing the 59 and 39 ends, respectively. The HDR donor oligo is indicated by the green arrows. The T.C
change is indicated in red. B. Surveyor nuclease assay on pooled ESC genomic DNA. Red arrowheads indicate nuclease cleavage products, diagnostic
of heterodimers. C. Distribution of Sap130 mutations. D. Sequence chromatograms showing homozygous T.C mutation.
doi:10.1371/journal.pone.0105779.g004
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targeting efficiency by more than 9-fold.
Discussion
Scarless, targeted genome modification using designer site-
directed nucleases such as CRISPR/Cas9 is a game changing
technology. Here we optimized several aspects of this approach to
enhance its efficiency. In a system where there is no selection for
the desired product, the most important step is to achieve efficient
transfection and then to enrich for transfected cells. Nucleofection
and LF3000 are good transfection options for murine ESCs.
Enrichment for transfected cells can be achieved by FACS sorting
for GFP co-expressed from the hCas9-GFP plasmid, or co-
transfection with a puromycin resistance marker followed by
transient puromycin selection [11]. We found that both enrich-
Figure 5. Cas9-mediated targeted knockin. A. Mef2c traditional targeting vector containing long homology arms, fl-bio epitope tag, and
positive selection cassette. Efficiency of traditional and Cas9-mediated targeting strategies is shown. B. Cas9-mediated targeting using a 50 bp
homology arms and no selectable marker. C. PCR genotyping of pooled ESC genomic DNA. Upper band is diagnostic of knockin. D. Confirmation of
knockin and effective epitope tagging by streptavidin pulldown of in vivo biotinylated Mef2c. E. Cas9-mediated knockin of a longer insert. F. PCR
genotyping of pooled ESC genomic DNA. The band is diagnostic of knockin. G. GFP expression after EB differentiation of a targeted clone.
doi:10.1371/journal.pone.0105779.g005
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yield a higher fraction of mutants with targeting of both alleles. On
the other hand, one advantange of transient puromyocin selection
is that cells do not need to leave the controlled environment of the
cell culture room and be processed on a FACS machine, with
attendant risks of mycoplasma or bacterial contamination.
It is important to consider downstream genotyping when
designing a gene targeting strategy. Small indel mutations
introduced by NHEJ using a single gRNA can be difficult to
detect without DNA sequencing. Sanger sequencing can become
expensive when many clones need to be screened. Moreover
standard Sanger sequencing data can be difficult to interpret
because indel mutations cause chromatogram phase shifts, so that
it can be difficult to distinguish homozygous and heterozygous
mutants [16]. We showed that dual gRNAs do not reduce (and
may marginally enhance) targeting efficiency and simplify
genotyping by causing more extensive deletions that are easily
detected by PCR genotyping. This strategy can also be used to
excise regions of DNA, such as transcriptional regulatory
sequences. One downside to the use of paired gRNAs for gene
knockout is that use of two gRNAs might increase the chance of
off-target genome modification. We showed that one gRNA plus a
DNA donor containing a stop codon enhances functional gene
knockout. Addition or removal of restriction sites in addition to a
stop codon or frameshift mutation in an HDR donor is an
alternative strategy to facilitate downstream genotyping [17],
although HR-dependent targeting tends to be several fold less
efficient than NHEJ.
It has been suggested that a ‘‘dual nick’’ strategy, in which two
gRNAs direct the Cas9D10A single strand nickase activity to
nearby sites to yield an effective double strand break, will be a
effective means to minimize off-target mutagenesis [11,13],
because the two gRNAs will rarely yield nearby nicks outside of
the target locus. Our data support this idea, since mutagenesis by
the nickase plus a single gRNA occurred at a low (but detectable)
frequency. Paired gRNAs that induced nearby nicks stimulated
mutagenesis by approximately 20-fold. Thus, efficient mutagenesis
with minimal off-target activity could best be achieved using the
Cas9D10A nickase and paired gRNAs. However, genotyping of
the resulting small indel mutations will be more labor intensive
and costly.
CRISPR/Cas9 greatly facilitates targeted genome modification
and introduction of new DNA sequences at a target locus. This
technology will facilitate generation of novel reagents, such as
proteins labeled with affinity or fluorescent tags. We explored the
variables that influence efficient introduction of new DNA
sequences at a target locus. The size of the insert was an
important variable, with larger inserts reducing the efficiency of
genome modification. For instance, at the Mef2c locus, changing
the insert length from 99 bp to 720 bp reduced modification
frequency 9-fold (36.3% to 4.3%). On the other hand, increasing
the homology arm size increased modification frequency: at the
Figure 6. Effect of homology arm length for Cas9-mediated knockin. A. GFP knockin at Oct4 C-terminus using 50 bp or 200 bp homology
arms. Knockin efficiency was measured by FACS for GFP expression. B–C. GFP expression in GFP
+ FACS clones by microscopy and western blotting.
D. PCR genotyping of individual ESC clones. The PCR product (arrowhead) is diagnostic of knockin at Oct4.
doi:10.1371/journal.pone.0105779.g006
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200 bp increased the frequency of inserting a 720 bp fragment by
8-fold (0.7% to 5.8%; note these are the frequencies of
modification of all cells, not transfected cells). Using TALENs to
induce HDR modification of a single nucleotide, Hendel et al.
showed that 400 bp homology arms improved HDR about 3-fold
compared to 200 bp, while 800 bp was equivalent to 400 bp [18].
Increasing homology arm size can compensate for increased
insert size. For example, at the Mef2c locus, an 2135 bp fragment
was introduced with 19.6% efficiency with 1 kb and 4 kb
homology arms. Using Gibson assembly [8], 200–400 bp homol-
ogy arms can be added to an insert with ease. Therefore, we
recommend use of homology arms of this length for larger DNA
insertions. For shorter inserts (,100 bp), 50 bp homology arms
are sufficient, so that the entire targeting construct can be
synthesized as an oligonucleotide.
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